Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001705033 | SCV000242088 | likely benign | not provided | 2020-09-01 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV000188474 | SCV000596485 | likely benign | not specified | 2019-03-18 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000528550 | SCV000660389 | likely benign | Developmental and epileptic encephalopathy, 12 | 2024-01-28 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000188474 | SCV000855682 | likely benign | not specified | 2017-07-27 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002381635 | SCV002689391 | likely benign | Inborn genetic diseases | 2018-02-06 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV001705033 | SCV004140473 | likely benign | not provided | 2023-04-01 | criteria provided, single submitter | clinical testing | PNKP: PP3, BS2 |
Prevention |
RCV003927744 | SCV004738025 | benign | PNKP-related condition | 2019-07-01 | criteria provided, single submitter | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |